Production and concentration of pseudotyped HIV-1-based gene transfer vectors

被引:135
作者
Reiser, J
机构
[1] Louisiana State Univ, Sch Med, LSU Gene Therapy Program, New Orleans, LA 70112 USA
[2] NINDS, Dev & Metab Neurol Branch, NIH, Bethesda, MD 20892 USA
关键词
lentiviral vectors; pseudotypes; gene therapy;
D O I
10.1038/sj.gt.3301188
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Strategies to generate highly concentrated HIV-1 vector pseudotypes involving different envelope (Env) proteins including the vesicular stomatitis virus (VSV) G glycoprotein, the Moloney murine leukemia virus (MLV) 4070A amphotropic Env and the rabies G glycoprotein were established. Virus stocks were prepared by transient transfection using standard cell culture media or serum-free media. Such stocks were concentrated 50- to 300-fold by ultracentrifugation or by ultrafiltration using Centricon Plus-80 units yielding titers of up to 10(9) transducing units per milliliter. There was no loss in titer with any of the pseudotypes tested. Thus, like lentiviral vectors pseudotyped with VSV-G, HIV-1-based vectors pseudotyped with the MLV 4070A amphotropic Env and the rabies G glycoprotein resist inactivation during concentration. This opens up the possibility to generate highly concentrated HIV-1 vector stocks carrying alternative Env proteins on a large scale.
引用
收藏
页码:910 / 913
页数:4
相关论文
共 12 条
[1]   Human immunodeficiency virus type 1 cell cycle control: Vpr is cytostatic and mediates G(2) accumulation by a mechanism which differs from DNA damage checkpoint control [J].
Bartz, SR ;
Rogel, ME ;
Emerman, M .
JOURNAL OF VIROLOGY, 1996, 70 (04) :2324-2331
[2]   VESICULAR STOMATITIS-VIRUS G GLYCOPROTEIN PSEUDOTYPED RETROVIRAL VECTORS - CONCENTRATION TO VERY HIGH-TITER AND EFFICIENT GENE-TRANSFER INTO MAMMALIAN AND NONMAMMALIAN CELLS [J].
BURNS, JC ;
FRIEDMANN, T ;
DRIEVER, W ;
BURRASCANO, M ;
YEE, JK .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1993, 90 (17) :8033-8037
[3]   HIV-1 REVERSE TRANSCRIPTION - A TERMINATION STEP AT THE CENTER OF THE GENOME [J].
CHARNEAU, P ;
MIRAMBEAU, G ;
ROUX, P ;
PAULOUS, S ;
BUC, H ;
CLAVEL, F .
JOURNAL OF MOLECULAR BIOLOGY, 1994, 241 (05) :651-662
[4]   Toward highly efficient cell-type-specific gene transfer with retroviral vectors displaying single-chain antibodies [J].
Chu, THT ;
Dornburg, R .
JOURNAL OF VIROLOGY, 1997, 71 (01) :720-725
[5]   HIGH-TITER PACKAGING CELLS PRODUCING RECOMBINANT RETROVIRUSES RESISTANT TO HUMAN SERUM [J].
COSSET, FL ;
TAKEUCHI, Y ;
BATTINI, JL ;
WEISS, RA ;
COLLINS, MKL .
JOURNAL OF VIROLOGY, 1995, 69 (12) :7430-7436
[6]   ANALYSIS OF MUTATION IN HUMAN-CELLS BY USING AN EPSTEIN-BARR-VIRUS SHUTTLE SYSTEM [J].
DUBRIDGE, RB ;
TANG, P ;
HSIA, HC ;
LEONG, PM ;
MILLER, JH ;
CALOS, MP .
MOLECULAR AND CELLULAR BIOLOGY, 1987, 7 (01) :379-387
[7]   High-titer human immunodeficiency virus type 1-based vector systems for gene delivery into nondividing cells [J].
Mochizuki, H ;
Schwartz, JP ;
Tanaka, K ;
Brady, RO ;
Reiser, J .
JOURNAL OF VIROLOGY, 1998, 72 (11) :8873-8883
[8]   Lentiviruses as gene transfer agents for delivery to non-dividing cells [J].
Naldini, L .
CURRENT OPINION IN BIOTECHNOLOGY, 1998, 9 (05) :457-463
[9]   In vivo gene delivery and stable transduction of nondividing cells by a lentiviral vector [J].
Naldini, L ;
Blomer, U ;
Gallay, P ;
Ory, D ;
Mulligan, R ;
Gage, FH ;
Verma, IM ;
Trono, D .
SCIENCE, 1996, 272 (5259) :263-267
[10]  
NALDINI L, 1999, COLD SPRING HARBOR M, V36, P47